Can the PHQ9 be signed electronically?

Yes. The PHQ9 can be signed electronically when the signer shows intent and consents, and the record is retained per ESIGN (15 U.S.C. ch. 96) and state UETA rules; certain exceptions (e.g., state-specific clinical consent) should be checked.

Is the PHQ9 protected health information?

Yes. Completed PHQ9 forms that identify a patient are protected health information under HIPAA and must be secured during storage and transmission. Implement access controls, audit trails, and, for vendor-hosted e-signatures, a Business Associate Agreement when PHI is processed.

How is the PHQ9 scored and interpreted?

Add scores for nine items (0–3 each) to produce a 0–27 total. Use standard thresholds (e.g., 5, 10, 15, 20) for mild, moderate, moderately severe, and severe depression to guide treatment decisions and need for safety assessment.

When should the PHQ9 be repeated?

Repeat at clinically appropriate intervals: after treatment initiation (4–12 weeks), on medication changes, or when symptoms worsen. Routine follow-up schedules vary by setting; document timing and rationale in the medical record to support care continuity and quality measurement.

Does the PHQ9 require notarization?

Generally no. PHQ9 is a clinical assessment and does not require notarization or witnesses for clinical validity. If the PHQ9 is used as part of a legal proceeding or administrative claim, verify notarization requirements with counsel or the relevant agency.

How long must PHQ9 records be retained?

Retain PHQ9 records per HIPAA and applicable state law: HIPAA requires six years from creation or last effective date (45 CFR §164.530(j)). State laws may require longer retention for medical records; verify local retention schedules.

Electronic Signature
Templates
Healthcare
Healthcare PHQ9 Form

Healthcare PHQ9 Form

This template is fully customizable. Edit the text, fill out the fields, and send it for signature. Give it a try!

PATIENT HEALTH QUESTIONNAIRE (PHQ-9)

The PHQ-9 is a standardized screening instrument used to assess the presence and severity of depressive symptoms over the prior two weeks. Responses will be used by clinical staff to assist in clinical assessment, treatment planning, and coordination of care. Information provided is confidential and will be maintained in the medical record subject to applicable law; confidentiality may be disclosed where there is imminent risk of harm to self or others, suspected abuse, or as required by court order.

Patient Information

Patient Name: Date of Birth:

Gender: Male Female Other Prefer not to say

Address Phone Email Emergency Contact

Insurance / Responsible Party

Insurance Provider

Policy Number

Group Number

Subscriber Name

Medical History

Current Medications Allergies Prior Surgeries / Hospitalizations Chronic Conditions Primary Care Provider Date of Assessment

PHQ-9 Questionnaire

Over the last 2 weeks, how often have you been bothered by any of the following problems?

1. Little interest or pleasure in doing things
Not at all (0) Several days (1) More than half the days (2) Nearly every day (3)

2. Feeling down, depressed, or hopeless
Not at all (0) Several days (1) More than half the days (2) Nearly every day (3)

3. Trouble falling or staying asleep, or sleeping too much
Not at all (0) Several days (1) More than half the days (2) Nearly every day (3)

4. Feeling tired or having little energy
Not at all (0) Several days (1) More than half the days (2) Nearly every day (3)

5. Poor appetite or overeating
Not at all (0) Several days (1) More than half the days (2) Nearly every day (3)

6. Feeling bad about yourself — or that you are a failure or have let yourself or your family down
Not at all (0) Several days (1) More than half the days (2) Nearly every day (3)

7. Trouble concentrating on things, such as reading the newspaper or watching television
Not at all (0) Several days (1) More than half the days (2) Nearly every day (3)

8. Moving or speaking so slowly that other people could have noticed? Or the opposite — being so fidgety or restless that you have been moving a lot more than usual
Not at all (0) Several days (1) More than half the days (2) Nearly every day (3)

9. Thoughts that you would be better off dead, or of hurting yourself in some way
Not at all (0) Several days (1) More than half the days (2) Nearly every day (3)

If you checked any response greater than 0 for question 9 (thoughts of self-harm), please notify clinical staff immediately. Presence of such thoughts may require further assessment and safety planning.

Over the last 2 weeks, how difficult have these problems made it for you to do your work, take care of things at home, or get along with other people?
Not difficult at all Somewhat difficult Very difficult Extremely difficult

Total PHQ-9 Score Clinician Notes / Recommended Action

Acknowledgment & Consent

I certify that the above information is true and complete to the best of my knowledge. I understand that the results of this screening will be placed in my medical record and used by clinical staff to inform diagnosis, treatment planning, and care coordination. I understand the limits of confidentiality as noted above and authorize clinicians to communicate relevant information with other treating providers for the purpose of my care.

I acknowledge and consent to the use and disclosure described above.

Additional Information

Additional Comments (optional)

Patient Name:

Signature:

Date:

Relationship to patient (if signed by guardian):

If signed by guardian, provide legal authority:

What the Healthcare PHQ9 Form Is and How It’s Used

The Healthcare PHQ9 Form is a standardized, nine-question patient self-report tool used in clinical settings to screen, diagnose, monitor severity, and track changes in depressive symptoms over time. It asks patients to rate the frequency of symptoms over the previous two weeks, producing a score that helps clinicians assess depression severity and treatment response. The form is widely used in primary care, behavioral health, and integrated care models. It is a clinical instrument, not a legal consent form, but must be handled under applicable privacy regulations when it contains protected health information.

Why use the Healthcare PHQ9 Form in clinical practice

Use the Healthcare PHQ9 Form to standardize depression screening, document symptom severity, and support treatment decisions. Proper completion and secure handling reduce clinical risk and enable measurement-based care while requiring compliance with HIPAA when the form contains protected health information.

Who completes and relies on PHQ9 results

Clinicians and care teams use the Healthcare PHQ9 Form to screen for depression and monitor treatment outcomes across settings.

Primary care physicians and nurse practitioners for routine screening, initial assessment, and follow-up in office-based care.
Psychiatrists, psychologists, and counselors for diagnostic clarification, treatment planning, and tracking symptom change over time.
Care managers, caseworkers, and telehealth clinicians for remote monitoring, triage, and coordinated care activities.

Health systems and researchers also use aggregated PHQ9 data to evaluate program outcomes and quality metrics.

Stepwise process to administer and record the PHQ9

Follow these steps to administer, score, and file the Healthcare PHQ9 Form correctly within clinical workflows.

01

Prepare: Confirm identity and explain purpose; obtain consent for electronic record storage.
02

Administer: Have patient complete questions privately; clarify wording if needed.
03

Score: Sum item responses to compute total 0–27 and categorize severity.
04

Document & Follow-up: Record score in the EHR; set safety plan for high scores.

Essential elements of a professional PHQ9 form

A professional Healthcare PHQ9 Form includes clear item wording, scoring instructions, clinician interpretation fields, and sections for safety planning and follow-up recommendations.

Standard Items

Nine items with consistent phrasing assessing frequency over two weeks, each scored 0–3. Use the exact item wording to preserve validity and comparability across administrations.

Scoring Guide

Clear instructions for summing item scores into a 0–27 total, with defined thresholds for severity categories and examples to guide interpretation in clinical notes and patient care.

Safety Protocol

Designated fields to document suicidal ideation, risk level, immediate actions taken, emergency contacts, and arranged follow-up; essential for liability mitigation and patient safety planning processes.

Clinician Notes

Space for clinician assessment, treatment plan, medication changes, and functional impairment observations; include signature, credentials, date, and follow-up timeline in EHR for legal clarity and documentation.

Patient Instructions

Concise, plain-language directions describing response options, confidentiality protections, and how results will be used in care planning; translated versions when required and contact resources provided.

Privacy Notice

Brief statement that completed forms are protected health information under HIPAA, who has access, and how to request records; include BAA note for third-party platforms.

Technical and compliance safeguards for PHQ9 data

In transit: TLS 1.2/1.3 encryption

At rest: AES-256 encryption at rest

Compliance: SOC 2 Type II certified

Healthcare PHI: HIPAA-compliant; Business Associate Agreement required

Audit Trail: Detailed timestamps and signer metadata

Regulatory: 21 CFR Part 11 support available

Principal risks and consequences of errors

Scoring Errors: Missed diagnosis or inappropriate care

Safety Misses: Unmanaged suicide risk exposure

Privacy Breach: HIPAA fines and corrective actions

Documentation Gaps: Insurance claim denials possible

Legal Liability: Malpractice exposure if negligent

Retention Violations: Regulatory penalties for improper retention

Common preparation and administration challenges

Patients may leave items blank or provide vague answers, reducing score validity and requiring clinician follow-up to clarify responses before diagnostic decisions.
Different administrators may paraphrase questions, altering item meaning; strict adherence to original wording is essential for score comparability and treatment thresholds.
Poor EHR mapping of score fields or missing clinician notes can cause billing errors, loss of longitudinal data, and reduced quality measurement accuracy.
Remote or proxy completion complicates authentication and consent; use appropriate signer verification and document who assisted or completed the form.

How an electronic PHQ9 workflow typically operates

Typical electronic PHQ9 workflow from creation to storage, focusing on security, authentication, scoring, and EHR integration.

Create form: Upload template and map fields for PHQ9 items.
Assign signer: Send secure link or invite via email/SMS.
Authenticate: Use email, SMS code, or stronger verification.
Store securely: Save signed PDF with audit trail in EHR.

Recommended configuration for an electronic PHQ9 workflow

Configure an electronic PHQ9 workflow with field mapping, signer options, authentication, storage, and notifications for clinical use.

Field	Configuration
Field Detection	Magic fields \| Auto-extract Q1–Q9
Authentication	Email/SMS \| Optional KBA or SSO
EHR Export	PDF + discrete \| HL7/FHIR mapping optional
Notifications	Clinician alerts \| Immediate for high scores

Platform requirements for secure eSubmission and storage

Required platform features for secure eSubmission, storage, and interoperability when handling PHQ9 data within clinical workflows.

File Formats: PDF and DOCX; editable templates supported
Integrations: EHR via FHIR/HL7 and API
Auth Options: Email, SMS, SSO, optional KBA

Timing and scheduling considerations for PHQ9 administration

Key timing considerations for PHQ9 administration, scoring, follow-up, and documentation to support clinical care and compliance.

Initial Screening Timing:

At intake or when depression suspected; document date.

Treatment Follow-up:

4–12 weeks after treatment initiation or sooner if symptoms severe.

Medication Changes:

Reassess after dose adjustments or new medications.

High-Risk Response:

Immediate safety assessment and crisis plan required same day.

Record Release Requests:

Respond per HIPAA timelines; verify identity before disclosure.

Key milestones from screening to follow-up

Sequential milestones from screening to follow-up for PHQ9 use in clinical workflows and quality assurance.

01

Screening

Patient completes PHQ9; staff confirm completeness.

02

Scoring

Clinician or system calculates total score and flags high values.

03

Review

Clinician evaluates results, documents interpretation, and assesses risk.

04

Action

Initiate treatment, referrals, or safety interventions as indicated.

Vendor pricing and feature comparison for eSignature platforms

Neutral feature and pricing comparison for eSignature vendors commonly used for clinical forms like the Healthcare PHQ9 Form; signNow appears first per table requirements.

	signNow	DocuSign	Adobe Sign	PandaDoc	HelloSign
Starting Price	$8/user/mo	$15/user/mo	$14/user/mo	$19/user/mo	$15/user/mo
Free Trial	7-day free trial	Varies	Varies	Limited trial	Limited trial
Bulk Send	Yes	Yes	Yes	Yes	No
Audit Trail	Yes	Yes	Yes	Yes	Yes
HIPAA Compliant	Yes	Yes	Yes	No	No

Frequently asked questions about the Healthcare PHQ9 Form

Answers to common questions about completing, storing, and legally handling the Healthcare PHQ9 Form in U.S. clinical practice.

Need help? Contact support

Can the PHQ9 be signed electronically?
Yes. The PHQ9 can be signed electronically when the signer shows intent and consents, and the record is retained per ESIGN (15 U.S.C. ch. 96) and state UETA rules; certain exceptions (e.g., state-specific clinical consent) should be checked.
Is the PHQ9 protected health information?
Yes. Completed PHQ9 forms that identify a patient are protected health information under HIPAA and must be secured during storage and transmission. Implement access controls, audit trails, and, for vendor-hosted e-signatures, a Business Associate Agreement when PHI is processed.
How is the PHQ9 scored and interpreted?
Add scores for nine items (0–3 each) to produce a 0–27 total. Use standard thresholds (e.g., 5, 10, 15, 20) for mild, moderate, moderately severe, and severe depression to guide treatment decisions and need for safety assessment.
When should the PHQ9 be repeated?
Repeat at clinically appropriate intervals: after treatment initiation (4–12 weeks), on medication changes, or when symptoms worsen. Routine follow-up schedules vary by setting; document timing and rationale in the medical record to support care continuity and quality measurement.
Does the PHQ9 require notarization?
Generally no. PHQ9 is a clinical assessment and does not require notarization or witnesses for clinical validity. If the PHQ9 is used as part of a legal proceeding or administrative claim, verify notarization requirements with counsel or the relevant agency.
How long must PHQ9 records be retained?
Retain PHQ9 records per HIPAA and applicable state law: HIPAA requires six years from creation or last effective date (45 CFR §164.530(j)). State laws may require longer retention for medical records; verify local retention schedules.

be ready to get more

Join over 28 million airSlate SignNow users

Sign Now